Autoimmune diseases arise from atypical immune responses that attack self-tissue epitopes,
and their development is intricately connected to the disruption of the JAK-STAT signaling …

Behçet´ s disease (BD) is a heterogeneous condition consisting of idiopathic systemic
vasculitis affecting large and small blood vessels of different types (ie, arteries, veins, or …

Behçet's Disease (BD) is an inflammatory disease of unknown etiology with multisystemic
involvement, being the main clinical manifestations represented by recurrent oral and …

Uveitis in Behçet's disease (BD) is frequent (40% of cases) and is a major cause of
morbidity. The age of onset of uveitis is between 20 and 30 years. Ocular involvement …

Introduction: Noninfectious uveitis (NIU) is one of the leading causes of blindness
worldwide. In adult patients, anterior NIU is usually managed with topical corticosteroids. In …

Introduction: Behçet's disease uveitis (BDU) is a potentially blinding disorder. Systemic
treatment with disease-modifying anti-rheumatic drugs (DMARDs) is mandatory in patients …

Acute anterior uveitis is the most common ocular manifestation in HLA-B27 positive
seronegative spondyloarthropathies. Suspicion for HLA-B27 associated uveitis should …

Ocular involvement in Behçet's syndrome still represents a challenge for both
rheumatologists and ophthalmologists; over the past 20 years the availability of new …

Behçet's disease (BD) is a systemic vasculitis disease of unknown origin occurring in young
people, which can be venous, arterial or both, classically occlusive. Ocular involvement is …

Behçet's uveitis (BU), a vision-threatening manifestation of Behçet's disease, poses
substantial management challenges due to its chronic, relapsing nature and potential for …